파로스백신

본문 바로가기
사이트 내 전체검색

파로스백신

PharoVax® FMD

Foot-and-Mouth Disease
Bivalent Recombinant Protein Oil Vaccine

PharoVax® FMD

  • Approval Number

    Number 361 - 1

  • Efficacy/Effectiveness

    Prevention of foot-and-mouth disease in pigs and cows
    Concurrent prevention of foot-and-mouth disease serotype O and serotype A

  • Dosage

    2 mL at each inoculation per pig or cow

  • Direction

    Initial immunization

    Primary inoculation is recommended on 8 weeks after birth in pigs and 4 months after birth in cows, intramuscularly.
    Second inoculation must be performed in the same manner after 4 weeks of primary inoculation.

    Additional immunization

    Inoculate every 6 months.
    In the event of a foot-and-mouth disease breakout, additional immunization is recommended regardless of schedule.

  • Characteristics and Advantages

    PharoVax-FMD is a marker vaccine.

    It is a vaccine that uses recombinant proteins as the immunogen, and cannot lead to any antibodies against non-structural proteins (NSP). Therefore, it is possible the differential diagnosis of animals that have been immunized by the vaccine or that have been infected by field virus.

    PharoVax-FMD can be easily optimized for each region or country.

    Vaccines for newly mutated viral strains can be developed within 2 to 3 months. Also, one product can be expanded to defend against various serotypes or lineages of foot-and-mouth disease viruses. Therefore, optimized vaccines can be provided for various types of foot-and-mouth disease viruses adapted to specific countries or regions.

회원로그인

접속자집계

오늘
1,051
어제
1,006
최대
1,446
전체
107,068

그누보드5
Copyright © 소유하신 도메인. All rights reserved.